Oligoadenylate-conjugated benzimidazole-based miR-210 inhibitor for breast cancer

DISEASE CATEGORY: Cancer

INDICATION: Breast cancer

In vitro and cell culture studies suggest a

Read the full 122 word article

User Sign In